A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension
Clinical trial NCT05343637 · COMPLETED
Trial details
- NCT number
- NCT05343637
- Sponsor
- Respira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2020-01-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.